| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
83,080
|
122,118
|
156,471
|
133,472
| | Cost of Revenue | 28,948 | 38,973 | 48,375 | 41,700 | | |
Gross Profit
|
54,132
|
83,145
|
108,096
|
91,772
| |
|
Operating Expenses |
|
Research Development | 38,149 | 36,101 | 36,229 | 37,658 |
|
Selling General and Administrative | 23,899 | 23,138 | 22,663 | 22,146 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(7,916)
|
23,906
|
49,204
|
31,968
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 213 | 269 | 585 | 221 |
|
Earnings Before Interest And Taxes | (7,703) | 24,175 | 49,789 | 32,189 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (7,703) | 24,175 | 49,789 | 32,189 |
|
Income Tax Expense | 754 | 5,733 | 1,386 | 100 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (8,457) | 18,442 | 48,403 | 32,089 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(8,457)
|
18,442
|
48,403
|
32,089
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(8,457)
|
18,442
|
48,403
|
32,089
|
|
0.71(1.43%) 10:20AM EDT - Nasdaq Real Time Price